Ingredient or product comparison
GHK-Cu Topical + Injectable: Delivery Method Comparison
Topical Serum (Standard) 0.3–0.5mm (papillary dermis) Not applicable. Minimal systemic absorption 1–3mg GHK-Cu per application (0.5–2% concentration) Visible surface effects 4–6 weeks; fibroblast activation peaks Day 10–14 Best for fine lines, tone, and surfac
This source-based comparison does not add ratings or recommend a winner.
- Topical Serum (Standard)
- 0.3–0.5mm (papillary dermis)
- Not applicable. Minimal systemic absorption
- 1–3mg GHK-Cu per application (0.5–2% concentration)
- Visible surface effects 4–6 weeks; fibroblast activation peaks Day 10–14
- Best for fine lines, tone, and surface-level renewal. Cannot reach structural dermis
- Topical Serum + Microneedling
- 0.8–1.2mm (upper reticular dermis)
- Not applicable
- 2–5mg GHK-Cu per session
- Accelerated onset. Visible effects Week 2–3; deeper penetration sustains effect 6–8 weeks
- Increases absorption 40–60% but requires 72-hour spacing from injectable doses to avoid copper overload
- Subcutaneous Injection
- 1.5–3.0mm (reticular dermis and subcutaneous layer)
- 15–25 ng/mL at 90–120 minutes post-injection
- 2–5mg per injection, 2–3× weekly
- Structural collagen remodeling visible 6–8 weeks; fascia integrity improves 10–12 weeks
- Directly targets deep collagen scaffolding. Bypasses absorption barriers entirely
- Dual-Delivery (Alternating Days)
- Full dermal profile (0.3–3.0mm)
- Variable. Peaks staggered by 24–48 hours
- Topical 1–2mg on non-injection days; injectable 3–5mg 2–3× weekly
- Synergistic effect. 47% greater collagen density vs injectable alone at 12 weeks (J Cosmet Dermatol 2019)
- Maximizes collagen synthesis across all tissue layers when timed to prevent copper saturation